Kiniksa Pharmaceuticals International (KNSA) total assets

Total assets · fiscal 2025
$763.63M

Kiniksa Pharmaceuticals International (KNSA) had total assets of $763.63M at the end of fiscal 2025 (December 31, 2025). That is 31.5% higher than the $580.55M of fiscal 2024. Figures as of 18 Nov 2026, 06:33 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2025
$763.63M
Change on fiscal 2024
+31.5%
Growth, 5 years
+16.9% a year
Highest on record
$763.63Mfiscal 2025
Lowest on record
$47.49Mfiscal 2017
Fiscal years on record
92017–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Kiniksa Pharmaceuticals International total assets, in more detail

Over the five fiscal years to 2025 total assets grew at a compound 16.9% a year. Across the 9 fiscal years on record (2017–2025), the highest was $763.63M in fiscal 2025 and the lowest $47.49M in fiscal 2017.

History · 9 fiscal years

Total assets by fiscal year

Kiniksa Pharmaceuticals International total assets, year by year

Kiniksa Pharmaceuticals International (KNSA) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2025$763.63M 31.5% up
2024$580.55M 10.3% up
2023$526.32M 14.5% up
2022$459.67M 97.5% up
2021$232.80M 33.4% down
2020$349.46M 37.3% up
2019$254.53M 20.9% down
2018$321.97M 577.9% up
2017$47.49M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

Total assets at health care companies of similar size

Total assets of Kiniksa Pharmaceuticals International and comparable companies
CompanyTotal assetsFiscal year
Alkermes ALKS$2.49B2025
PACS Group PACS$5.58B2025
Kiniksa Pharmaceuticals International KNSA$763.63M2025
ImmunityBio IBRX$501.90M2025
Cytokinetics CYTK$1.42B2025
ABIVAX ABVX€584.34M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on KNSA

Kiniksa Pharmaceuticals International, figure by figure

Kiniksa Pharmaceuticals International (KNSA) overview: price, valuation and scorecardAll health care companies by market value

Kiniksa Pharmaceuticals International total assets: questions and answers

How large are Kiniksa Pharmaceuticals International's total assets?

Kiniksa Pharmaceuticals International (KNSA) had total assets of $763.63M at the end of fiscal 2025 (December 31, 2025). That is 31.5% higher than the $580.55M of fiscal 2024.

What is the growth rate of Kiniksa Pharmaceuticals International's total assets?

Over the five fiscal years to 2025 total assets grew at a compound 16.9% a year.

What are the highest and lowest total assets figures on record for Kiniksa Pharmaceuticals International?

Across the 9 fiscal years on record (2017–2025), the highest was $763.63M in fiscal 2025 and the lowest $47.49M in fiscal 2017.

How is Kiniksa Pharmaceuticals International's total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Kiniksa Pharmaceuticals International (KNSA) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/KNSA/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.